|Fax||+44 (0)1865 617 202|
Misghina T. Weldegiorgis
Letters after your name
- Additional job titles
Misghina Weldegiorgis is an epidemiologist at The George Institute for Global Health at the University of Oxford.
His current work focuses on quantifying the sex-specific associations between the major risk factors and the incidence of common NCDs, such as cardiovascular disease and chronic kidney disease.
Misghina earned his BSc degree in Pharmacy from the University of Asmara and MSc degree in Epidemiology from Utrecht University. He is nearly completing his Ph.D. (2017) from the University Medical Center Groningen.
Specialties: Evaluation of renal endpoints for clinical trials, longitudinal analysis, multivariate analysis, chronic kidney disease, diabetic nephropathy, and cardiovascular diseases.
Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?
Weldegiorgis M. et al, (2017), Clin J Am Soc Nephrol, 12, 1595 - 1600
Renal end points in clinical trials of kidney disease.
Weldegiorgis M. et al, (2015), Curr Opin Nephrol Hypertens, 24, 284 - 289
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).
Lambers Heerspink HJ. et al, (2014), Am J Kidney Dis, 63, 244 - 250